DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part of the
legislative instrument. The keyword, one-liner, abstract, and digest do not constitute part of the law
or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
HB 813 Original 2024 Regular Session Edmonston
Abstract: Provides that neither the La. Dept. of Health nor any healthcare professional licensing
board of the state shall prohibit or restrict the prescribing, administering, or dispensing of
drugs for off-label use.
Present law provides for licensure and regulation by the state of various types of healthcare
professionals.
Proposed law retains present law and stipulates that neither the La. Dept. of Health nor any
healthcare professional licensing board or commission shall prohibit or restrict the prescribing,
administering, or dispensing for an off-label use a drug that has been approved for a specific use by
the U.S. Food and Drug Administration (FDA).
Proposed law defines "off-label use", for purposes of proposed law, as the use of a prescription drug
for an indication for which it has not been approved by the FDA or the use of such drug in an age
group, dosage, or route of administration that has not been approved by the FDA.
(Adds R.S. 37:1704)